Effects of estradiol alone and combined with norethisterone acetate on pulse-wave velocity in hypertensive postmenopausal women

Gynecological Endocrinology

Volumn 22, Issue 10, 2006, Pages 557-563

  Arruda, C G ^a,b   Aldrighi, J M ^a   Bortolotto, L A ^a   Alecrin, I N ^a   Ramires, J A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Arterial stiffness; Estrogen; Hypertension; Menopause; Progestogen; Pulse wave velocity

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; ESTRADIOL; ESTROGEN; GESTAGEN; NORETHISTERONE ACETATE; PLACEBO; VASODILATOR AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTERY STIFFNESS; ARTICLE; BLOOD VESSEL PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON CAROTID ARTERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEVICE; DOUBLE BLIND PROCEDURE; ESTROGEN BLOOD LEVEL; FEMALE; FEMORAL ARTERY; HORMONAL THERAPY; HUMAN; HYPERTENSION; MEASUREMENT; POSTMENOPAUSE; PRESSURE TRANSDUCER; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERIES; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTRADIOL; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; NORETHINDRONE; PLACEBOS; POSTMENOPAUSE; PULSE; VASCULAR RESISTANCE;

EID: 33845355522     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590601005342     Document Type: Article

References (42)

1. Mansur AP, Aldrighi JA, Ramires JAF. Trends in death from circulatory diseases in Brazil between 1979 and 1996. Arq Bras Cardiol 2001;76:504-510.
2. Aldrighi JM, Martinez TLR, Silva FCP. Cardiovascular disease and hormone replacement therapy. Arq Bras Cardiol 1995;65:249-254.
3. Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids 1990;55:330-352.
4. Staessen JA, Celis H, Fagard R. The epidemiology of the association between hypertension and menopause. J Hum Hypertens 1998;12:587-592.
5. Sauerbronn AVD, Fonseca AM, Bagnoli VR, Saldiva PH. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000;68:35-41.
6. Bourne T, Hillard TC, Whitehead MI, Crook D, Campbell S. Oestrogens arterial status and postmenopausal women. Lancet 1990;355:1470-1471.
7. Herrington D, Braden GA, Williams JK, Morgan TM. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol 1994;73:951-952.
8. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
9. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786-791.
10. Alecrin IN, Aldrighi JM, Caldas MA, Gebara OCE, Lopes NHM, Ramires JAF. Acute and chronic effects of estradiol on left ventricular diastolic function in hypertensive postmenopausal women with left ventricular diastolic dysfunction. Heart 2004;90:777-781.
11. Riedel M, Oeltermann A, Mugge A, Creutzig A, Rafflenbeul W, Lichetlen P. Vascular responses to 17β-oestradiol in postmenopausal women. Eur J Clin Invest 1995;25:44-47.
12. McDonald DA. Blood flow in arteries: Theoretical, experimental and clinical principles. 4th ed. London: Arnold; 1998. pp 77-142, 216-269, 283-359, 398-437.
13. Bortolotto LA, Blacher J, Kondo T, Takazawa K, Safar ME. Assessment of vascular aging and atherosclerosis in hypertensive subjects: second derivate of photoplethysmogram versus pulse wave velocity. Am J Hypertens 2000;13:165-171.
14. Rajkumar C, Kingwell BA, Cameron JD, Waddell T, Mehra R, Christophidis N, Komesaroff PA, McGrath B, Jennings GL, Sudhir K, et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol 1997;30:350-356.
15. Stefanadis C, Tsiamis E, Dernellis J, Toutouzas P. Effect of estrogen on aortic function in postmenopausal women. Am J Physiol 1999;276(2 Pt 2):H658-H662.
16. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997;157:2413-2446.
17. Blacher J, Guerin A, Pannier B, Marchais S, Safar M, London G. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999;99:2434-2439.
18. Blacher J, Asmar R, Djane S, London G, Safar M. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999;3:1111-1117.
19. Bortolotto LA, Safar ME, Billaud E, Lacroix C, Asmar R, London GM, Blacher J. Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension 1999;34:837-842.
20. Lehmann ED, Riley WA, Clarkson P, Gosling RG. Non invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 1997;350(Suppl 1):14-19.
21. Asmar R, Topouchian J, Pannier B, Benetos A, Safar M. Pulse wave velocity as endpoint in large-scale intervention trial. The Complior Study. J Hypertens 2001;19:813-818.
22. Bank AJ, Kaiser DR. Smooth muscle relaxation: effects on arterial compliance, distensibility, elastic modulus, and pulse wave velocity. Hypertension 1998;32:356-359.
23. Cohn JN. Vascular wall function as a risk marker for cardiovascular disease. J Hypertens 1999;17(Suppl 5):S41-S44.
24. Asmar R, Benetos A, Topouchian J, Laurent S, Pannier B. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995;26:485-490.
25. Teede HJ, Lorang YL, Kotsopoulos D. A placebo-controlled trial of long-term combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol (Oxf) 2001;55:673-682.
26. Tanaka H, De Souza CA, Seals DR. Arterial stiffness and hormonal replacement use in healthy postmenopausal women. J Gerontol 1998;53:M344-M346.
27. Waddell TK, Rajkumar C, Cameron JD, Jennings GL, Dart AM, Kingwell BA. Withdrawal of hormonal therapy for 4 weeks decreases arterial compliance in postmenopausal women. J Hypertens 1999;17:413-418.
28. Blacher J, Raison J, Safar MG. Increase arterial distensibility in postmenopausal hypertensive women with and without hormone replacement therapy after agude administration of the ace inhibitor moexipril. Cardiovasc Drugs Ther 1998;12:409-414.
29. Sumino H, Ichikawa S, Kasama S, Takahashi T, Kumakura H, Takayama Y, Kanda T, Kurabayashi M. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women. Atherosclerosis 2006 Feb 7 [Epub ahead of print].
30. Cameron JD. Estimation of arterial mechanics in clinical practice and as a research technique. Clin Exp Pharmacol Physiol 1999;26:285-294.
31. PEPI Trial. Effects of estrogen or estrogen/progestin regiments on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. J Am Med Assoc 1995;273:199-208.
32. Pfeffer R, Kurosaki TT, Charlton S. Estrogen use and blood pressure in later life. Am J Epidemiol 1979;110:469-478.
33. Vilodre LC, Osorio Wender MC, Sisson de Castro JA, Reis FM, Ruscher S, Magalhães JA, Spritzer PM. Endometrial response to a cyclic regimen of percutaneous 17 g estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension. Gynecol Endocrinol 2003;17:323-328.
34. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, O'Rourke MF. Effects of aging on arterial distensibiity in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation 1985;71:202-210.
35. Banka CL. Non-genomic actions of estrogens as antioxidants. In: Rubanyi GM, Kauffman R, editors. Estrogen and vessel wall. Australia: Harwood Academic Publishers; 1998. pp 91-106.
36. Alper T, Cetinkaya MB, Kokcu A, Yanik FF, Malatyalioglu E. Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time? Gynecol Endocrinol 2004;18:199-205.
37. Sitruk-Ware R. Progestins and the cardiovascular system. In: Genazzani AR, editor. Hormone replacement therapy and cardiovascular disease. New York: Parthenon; 2001. pp 93-100.
38. Girerd X, Chanudet X, Larrogue P, Safar ME. Early arterial modifications in young patients with borderline hypertension. J Hypertens 1989;7(Suppl 1):456-457.
39. Rosano GM, Mercuro G, Vitale C, Rosini P, Galetta P, Fini M. How progestins influence the cardiovascular effect of hormone replacement therapy. Gynecol Endocrinol 2001;15(Suppl 6):9-17.
40. Oliveira RL, Aldrighi JM, Gebara OE, Rocha TR, D'Amico E, Rosano GM, Ramires JA. Postmenopausal hormone replacement therapy increases plasmatic thromboxane β2. Int J Cardiol 2005;99:449-454.
41. Sitruk-Ware R, Sundaram K. Pharmacology of new progestogens: the 19-nonprogesterone derivatives. In: Sitruk-Ware R, Mishell DR Jr, editors. Progestins and antiprogestins in clinical practice. New York: Marcel Dekker Inc.; 2000. pp 156-61.
42. Miura S, Tanaka E, Mori A, Toya M, Takahashi K, Nakahara K, Ohmichi M, Kurachi H. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 2003;45:293-298.